-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
-
-
-
-
-
-
-
JPMorgan analysts name top short ideas for third quarter 2026
-
-
-
-
-
-
-
Moderna (MRNA) PT Raised to $77 at Piper Sandler
-
-
-
-
-
-
-
Moderna Wins Fda Panel Backing For Mrna Flu Vaccine
-
-
-
-
-
-
-
Moderna (MRNA) sees strong intraday gains
-
-
-
-
-
-
-
Moderna (MRNA) call put ratio 14 calls to 1 put with a focus on May 22 weekly 52, 55 and 57 calls
-
-
-
-
-
-
-
Bernstein: 'Hantavirus boosting interest in Moderna (MRNA)'
-
443,891 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

